Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER Breast Cancer. (Q52951832)
Jump to navigation
Jump to search
scientific article published on 30 November 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER Breast Cancer. |
scientific article published on 30 November 2016 |
Statements
Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER Breast Cancer. (English)
1 reference
Sarah R Hosford
1 reference
Lloye M Dillon
1 reference
Stephanie J Bouley
1 reference
Rachele Rosati
1 reference
Wei Yang
1 reference
Vivian S Chen
1 reference
Eugene Demidenko
1 reference
Rocco P Morra
1 reference
Todd W Miller
1 reference
30 November 2016
1 reference
23
1 reference
11
1 reference
2795-2805
1 reference
Identifiers
1 reference